Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Oct 04 04:00PM ET
13.88
Dollar change
+0.97
Percentage change
7.51
%
IndexRUT P/E- EPS (ttm)-2.69 Insider Own54.83% Shs Outstand41.13M Perf Week16.64%
Market Cap690.25M Forward P/E- EPS next Y-3.36 Insider Trans-2.84% Shs Float22.46M Perf Month16.25%
Income-119.67M PEG- EPS next Q-0.86 Inst Own45.83% Short Float6.55% Perf Quarter10.60%
Sales0.00M P/S- EPS this Y-65.66% Inst Trans7.92% Short Ratio8.11 Perf Half Y6.85%
Book/sh5.84 P/B2.38 EPS next Y-1.98% ROA-39.26% Short Interest1.47M Perf Year49.73%
Cash/sh6.26 P/C2.22 EPS next 5Y- ROE-41.62% 52W Range5.85 - 16.91 Perf YTD61.40%
Dividend Est.- P/FCF- EPS past 5Y- ROI-41.25% 52W High-17.89% Beta1.77
Dividend TTM- Quick Ratio11.20 Sales past 5Y0.00% Gross Margin- 52W Low137.26% ATR (14)0.64
Dividend Ex-Date- Current Ratio11.20 EPS Y/Y TTM- Oper. Margin0.00% RSI (14)70.82 Volatility6.00% 5.23%
Employees28 Debt/Eq0.00 Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price32.50
Option/ShortYes / Yes LT Debt/Eq0.00 EPS Q/Q-179.61% Payout- Rel Volume0.90 Prev Close12.91
Sales Surprise- EPS Surprise-18.57% Sales Q/Q- EarningsAug 13 AMC Avg Volume181.42K Price13.88
SMA2016.56% SMA5018.31% SMA20014.14% Trades Volume163,185 Change7.51%
Date Action Analyst Rating Change Price Target Change
Jul-10-24Initiated H.C. Wainwright Buy $30
Apr-02-24Initiated Goldman Buy $30
Mar-07-23Initiated Wells Fargo Overweight $27
Mar-07-23Initiated Stifel Buy $45
Mar-07-23Initiated Guggenheim Buy $32
Mar-07-23Initiated Evercore ISI Outperform
Mar-07-23Initiated Credit Suisse Outperform $40
Mar-07-23Initiated BofA Securities Buy $39
Sep-25-24 08:00AM
Aug-28-24 08:00AM
Aug-13-24 04:05PM
Aug-05-24 04:05PM
Jul-12-24 07:01PM
07:01PM Loading…
07:01PM
Jun-21-24 03:11AM
Jun-15-24 02:53AM
Jun-14-24 08:00AM
02:43AM
Jun-03-24 08:00AM
May-13-24 11:45AM
May-09-24 11:56AM
07:00AM
May-06-24 08:00AM
08:00AM Loading…
May-02-24 08:00AM
Apr-05-24 12:16AM
Mar-22-24 10:51AM
Mar-21-24 11:53AM
09:11AM
07:00AM
Mar-13-24 04:05PM
Feb-08-24 08:00AM
Jan-29-24 04:05PM
Jan-17-24 12:00PM
Jan-04-24 04:05PM
Dec-21-23 04:05PM
Nov-12-23 09:22AM
Nov-11-23 11:30AM
Nov-09-23 04:05PM
05:12PM Loading…
Nov-07-23 05:12PM
04:05PM
Nov-02-23 10:00AM
Oct-31-23 04:05PM
Oct-13-23 04:10PM
Sep-19-23 04:00PM
Sep-14-23 04:05PM
Sep-11-23 04:05PM
Sep-10-23 07:47AM
07:45AM
Sep-09-23 05:00AM
Sep-05-23 04:05PM
09:55AM
Aug-29-23 04:05PM
Aug-22-23 05:45PM
Aug-07-23 04:05PM
Jul-31-23 04:05PM
Jul-17-23 04:01PM
Jun-09-23 08:04AM
May-31-23 08:00AM
May-15-23 04:01PM
May-10-23 08:39AM
May-02-23 08:00AM
May-01-23 08:00AM
Apr-27-23 04:47PM
Mar-15-23 04:01PM
Mar-04-23 04:30PM
Mar-01-23 04:05PM
Feb-20-23 08:00AM
Feb-17-23 12:08PM
Feb-14-23 04:01PM
Feb-10-23 05:16PM
Mineralys Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing medicines to target diseases driven by abnormally elevated aldosterone. Its clinical-stage product candidate, lorundrostat, is a proprietary, orally administered, highly selective aldosterone synthase inhibitor that are initially developing for the treatment of cardiorenal conditions affected by abnormally elevated aldosterone, including hypertension and chronic kidney disease. The company was founded by Brian Taylor Slingsby on May 31, 2019 and is headquartered in Radnor, PA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Rodman David MalcomChief Medical OfficerSep 12 '24Option Exercise1.086,3496,857125,605Sep 12 04:32 PM
Rodman David MalcomChief Medical OfficerSep 11 '24Option Exercise0.545,0182,710119,256Sep 12 04:32 PM
Rodman David MalcomChief Medical OfficerAug 12 '24Option Exercise0.8411,3659,565114,238Aug 13 04:20 PM
Slingsby Brian TaylorDirectorJul 24 '24Sale13.05550,0007,177,5008,644,579Jul 26 09:45 PM
Rodman David MalcomChief Medical OfficerJul 16 '24Option Exercise1.08525567103,398Jul 18 06:34 PM
Rodman David MalcomChief Medical OfficerJul 16 '24Sale15.005257,876102,873Jul 18 06:34 PM
Rodman David MalcomChief Medical OfficerJul 12 '24Option Exercise1.086,3496,857102,873Jul 12 04:39 PM
Rodman David MalcomChief Medical OfficerJul 11 '24Option Exercise0.545,0172,70996,524Jul 12 04:39 PM
Levy Adam ScottCFO and SecretaryJul 11 '24Sale13.1410,757141,394247,611Jul 12 04:37 PM
Congleton JonChief Executive OfficerJul 11 '24Sale13.3415,746210,075911,212Jul 12 04:36 PM
Congleton JonChief Executive OfficerJun 17 '24Sale12.2517,766217,712958,505Jun 20 05:44 PM
Congleton JonChief Executive OfficerJun 18 '24Sale11.9916,607199,073941,898Jun 20 05:44 PM
Congleton JonChief Executive OfficerJun 20 '24Sale11.7314,940175,237926,958Jun 20 05:44 PM
Congleton JonChief Executive OfficerJun 13 '24Sale12.7439,961509,027992,500Jun 14 06:15 PM
Congleton JonChief Executive OfficerJun 12 '24Sale12.7716,607212,0131,032,461Jun 14 06:15 PM
Congleton JonChief Executive OfficerJun 14 '24Sale12.5216,229203,163976,271Jun 14 06:15 PM
Levy Adam ScottCFO and SecretaryJun 11 '24Sale12.9496,8151,252,718255,462Jun 13 05:33 PM
Rodman David MalcomChief Medical OfficerJun 12 '24Option Exercise1.086,3496,85789,729Jun 13 05:32 PM
Rodman David MalcomChief Medical OfficerJun 11 '24Option Exercise0.545,0172,70983,380Jun 13 05:32 PM
Rodman David MalcomChief Medical OfficerMay 13 '24Option Exercise0.8411,3669,56678,363May 15 04:43 PM
Rodman David MalcomChief Medical OfficerMay 09 '24Option Exercise1.0810010867,097May 10 04:17 PM
Rodman David MalcomChief Medical OfficerMay 09 '24Sale15.001001,50066,997May 10 04:17 PM
Rodman David MalcomChief Medical OfficerApr 12 '24Option Exercise1.086,3496,85766,997Apr 15 04:24 PM
Rodman David MalcomChief Medical OfficerApr 11 '24Option Exercise0.545,0172,70960,648Apr 15 04:24 PM
Rodman David MalcomChief Medical OfficerMar 12 '24Option Exercise1.086,3486,85655,631Mar 13 05:35 PM
Rodman David MalcomChief Medical OfficerMar 11 '24Option Exercise0.545,0172,70949,283Mar 13 05:35 PM
Samsara BioCapital GP, LLC10% OwnerFeb 12 '24Buy13.50555,5557,499,9925,074,916Feb 14 09:06 PM
Rodman David MalcomChief Medical OfficerFeb 12 '24Option Exercise0.8411,3669,56644,266Feb 13 04:08 PM
Rodman David MalcomChief Medical OfficerJan 12 '24Option Exercise1.086,3486,85632,900Jan 12 04:01 PM
Rodman David MalcomChief Medical OfficerJan 11 '24Option Exercise0.545,0172,70926,552Jan 12 04:01 PM
Rodman David MalcomChief Medical OfficerDec 11 '23Option Exercise0.545,0182,71020,069Dec 12 05:08 PM
Congleton JonChief Executive OfficerNov 22 '23Buy5.974,25025,3561,049,068Nov 27 04:01 PM
Rodman David MalcomChief Medical OfficerNov 13 '23Option Exercise0.545,0172,70915,051Nov 14 06:18 PM
Rodman David MalcomChief Medical OfficerNov 03 '23Option Exercise0.5410,0345,41810,034Nov 07 05:15 PM